The Revised Schedule M has introduced critical updates that impact the manufacture of Oral Solid Dosage Forms (OSD) such as tablets, capsules, and granules. This course provides in-depth insights into the current regulatory expectations, infrastructure upgrades, quality systems, and documentation practices required for OSD facilities.

Through this training, participants will gain clarity on compliance requirements, design considerations, and GMP practices specifically applicable to OSD manufacturing in the Indian pharmaceutical ecosystem.